…and some to hold, avoid or sell

Caledonia Mining Investors Chronicle

The African miner’s first-half profits are up, but so are its operating costs – and missed production growth targets have helped to reduce cash by 58%. Two fatalities at the Blanket mine have rocked confidence. Sell. 645p.

Drax The Mail on Sunday

Power producer Drax spotted an opportunity when a CO2 shortage took the fizz out of our pints. It is now trialling bioenergy carbon capture and storage – a new sideline showing welcome diversification. Hold. 373.75p.

Hikma Pharmaceuticals The Times

The drugs-maker’s annual revenues have jumped 10% – a turnaround after a tough year and ahead of forecasts. But the volatile US market accounts for some 66% of business, and the recovery is already priced in. Hold. £17.45.

JPJ Group The Times

Having gone through a few name changes and sold its social gaming business, the online bingo operator is now looking to decrease reliance on the UK market as growth slows. It’s set to pay its first dividend. Hold. 950p.

Investors Chronicle

The recruiter offers a rosy take on the global economy. Net fees are up 14% and profitability is rising in Europe, the Middle East and Africa. But ongoing trade war fears mean this may not be time to buy in. Hold. 608p.

TP Icap Investors Chronicle

The integration of a voicebroking acquisition has given the financial services firm a good deal of trouble: shares have dropped 41% in a year. Lacklustre growth has led to adjusted profit expectations. Hold. 290.2p.